Furthermore, the downregulation of NET formation, suppression of CD4+ and CD8+ T cell mediated toxicity, and inhibition of M1 polarization of monocytes in the UC-MSC-treated animals collectively inhibit with the pathological processes that drive ARDS. The gene discussed is CD4; the disease is acute respiratory distress syndrome.